Cerebral amyloid angiopathy and Alzheimer disease—one peptide, two pathways

SM Greenberg, BJ Bacskai… - Nature Reviews …, 2020 - nature.com
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and
Alzheimer disease (AD) is arguably the clearest instance of crosstalk between …

Traumatic brain injury and Alzheimer's disease: the cerebrovascular link

J Ramos-Cejudo, T Wisniewski, C Marmar… - …, 2018 - thelancet.com
Traumatic brain injury (TBI) and Alzheimer's disease (AD) are devastating neurological
disorders, whose complex relationship is not completely understood. Cerebrovascular …

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

BV Zlokovic - Nature Reviews Neuroscience, 2011 - nature.com
The neurovascular unit (NVU) comprises brain endothelial cells, pericytes or vascular
smooth muscle cells, glia and neurons. The NVU controls blood–brain barrier (BBB) …

The hCMEC/D3 cell line as a model of the human blood brain barrier

B Weksler, IA Romero, PO Couraud - Fluids and Barriers of the CNS, 2013 - Springer
Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs)
in order to model the blood–brain barrier (BBB) in vitro, the need for a human BBB model …

Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?

K Govindpani, LG McNamara, NR Smith… - Journal of clinical …, 2019 - mdpi.com
Alzheimer's disease (AD) is the most prevalent form of dementia. Despite decades of
research following several theoretical and clinical lines, all existing treatments for the …

Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease

KE Biron, DL Dickstein, R Gopaul, WA Jefferies - PloS one, 2011 - journals.plos.org
Evidence of reduced blood-brain barrier (BBB) integrity preceding other Alzheimer's disease
(AD) pathology provides a strong link between cerebrovascular angiopathy and AD …

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease

AP Sagare, RD Bell… - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Neurovascular dysfunction is an integral part of Alzheimer disease (AD). Changes in the
brain vascular system may contribute in a significant way to the onset and progression of …

Familial Alzheimer's disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-β peptide

A Hatami, S Monjazeb, S Milton, CG Glabe - Journal of Biological Chemistry, 2017 - ASBMB
Most cases of Alzheimer's disease (AD) are sporadic, but a small percentage of AD cases,
called familial AD (FAD), are associated with mutations in presenilin 1, presenilin 2, or the …

Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and Alzheimer's …

RM Parodi-Rullán, S Javadov, S Fossati - Cells, 2021 - mdpi.com
Alzheimer's disease (AD) is the most prevalent cause of dementia and is pathologically
characterized by the presence of parenchymal senile plaques composed of amyloid β (Aβ) …

Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice

M Merlini, EP Meyer, A Ulmann-Schuler… - Acta neuropathologica, 2011 - Springer
Cerebrovascular lesions related to congophilic amyloid angiopathy (CAA) often accompany
deposition of β-amyloid (Aβ) in Alzheimer's disease (AD), leading to disturbed cerebral …